General Information of the Compound
Compound ID
CP0443632
Compound Name
1-carbazol-9-yl-3-(1,1-dioxo-1,2,5-thiadiazolidin-2-yl)propan-2-ol
    Show/Hide
Structure
Formula
C17H19N3O3S
Molecular Weight
345.424
Canonical SMILES
OC(CN1CCNS1(=O)=O)Cn1c2ccccc2c2ccccc12
    Show/Hide
InChI
InChI=1S/C17H19N3O3S/c21-13(11-19-10-9-18-24(19,22)23)12-20-16-7-3-1-5-14(16)15-6-2-4-8-17(15)20/h1-8,13,18,21H,9-12H2
    Show/Hide
InChIKey
FRCDZLULLXDCGH-UHFFFAOYSA-N
Physicochemical Property
logP
1.3054
Rotatable Bonds
4
Heavy Atom Count
24
Polar Areas
74.57
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
4
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 127037261
ChEMBL ID
CHEMBL3753487
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06468, Period circadian protein homolog 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000043 U2OS Homo sapiens (Human)  1
1
EC50 = 42 nM
   TI
   LI
   LO
   TS